These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25245932)

  • 1. HIV-associated juvenile systemic sclerosis: a case report.
    Okong'o LO; Webb K; Scott C
    Semin Arthritis Rheum; 2015 Feb; 44(4):411-6. PubMed ID: 25245932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cyclophosphamide pulse therapy for pediatric systemic sclerosis].
    Iwata N; Miyamae T; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S; Kondo M; Sasaki T; Ikezawa Y
    Ryumachi; 2003 Oct; 43(4):660-6. PubMed ID: 14598659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heart involvement in systemic sclerosis: analysis of four cases].
    Wielosz E; Borys O; Błaszczak P; Majdan M
    Ann Acad Med Stetin; 2012; 58(1):33-9; discussion 39. PubMed ID: 23547392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders.
    Iudici M; Cuomo G; Vettori S; Bocchino M; Sanduzzi Zamparelli A; Cappabianca S; Valentini G
    Semin Arthritis Rheum; 2015 Feb; 44(4):437-44. PubMed ID: 25282395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide versus placebo in scleroderma lung disease.
    Tashkin DP; Elashoff R; Clements PJ; Goldin J; Roth MD; Furst DE; Arriola E; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M;
    N Engl J Med; 2006 Jun; 354(25):2655-66. PubMed ID: 16790698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial lung disease associated with systemic sclerosis: what is the evidence for efficacy of cyclophosphamide?
    Bérezné A; Valeyre D; Ranque B; Guillevin L; Mouthon L
    Ann N Y Acad Sci; 2007 Sep; 1110():271-84. PubMed ID: 17911442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of manifestations of HIV infection in a case of systemic lupus erythematosus following treatment with IV cyclophosphamide.
    Hazarika I; Chakravarty BP; Dutta S; Mahanta N
    Clin Rheumatol; 2006 Feb; 25(1):98-100. PubMed ID: 16132163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brachial plexopathy associated with diffuse edematous scleroderma.
    Mouthon L; Halimi C; Dussaule Md JC; Cayre-Castel Md M; Guillevin L
    Ann Med Interne (Paris); 2000 Jun; 151(4):303-5. PubMed ID: 10922959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyclophosphamide treatment in patients with systemic sclerosis].
    Chwieśko S; Kowal-Bielecka O; Sierakowski S
    Postepy Hig Med Dosw (Online); 2006; 60():300-6. PubMed ID: 16767054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis.
    Vallance DK; Lynch JP; McCune WJ
    Curr Opin Rheumatol; 1995 May; 7(3):174-82. PubMed ID: 7612408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chorioretinitis in a 7-year-old African girl, probably related to JSSc resolving to methotrexate therapy.
    Hedrich CM; Leszczynska A; Hammermann J; Bau V; Gahr M
    Klin Padiatr; 2011 Mar; 223(2):92-4. PubMed ID: 21294066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transverse myelitis in systemic sclerosis.
    Torabi AM; Patel RK; Wolfe GI; Hughes CS; Mendelsohn DB; Trivedi JR
    Arch Neurol; 2004 Jan; 61(1):126-8. PubMed ID: 14732630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of juvenile systemic sclerosis with disease onset at six months old.
    Sato S; Ishida W; Takehara K
    Clin Rheumatol; 2003 May; 22(2):162-3. PubMed ID: 12740689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile systemic sclerosis: experience from a tertiary care center from India.
    Bagri NK; Raj D; Kaur J; Punia H; Saini I; Lodha R; Kabra SK
    Rheumatol Int; 2017 Oct; 37(10):1687-1691. PubMed ID: 28831595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
    Wanchu A; Suryanaryana BS; Sharma S; Sharma A; Bambery P
    Int J Rheum Dis; 2009 Sep; 12(3):239-42. PubMed ID: 20374353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations.
    Henes JC; Koetter I; Horger M; Schmalzing M; Mueller K; Eick C; Bauer A; Vogel W; Kanz L
    Rheumatology (Oxford); 2014 May; 53(5):919-22. PubMed ID: 24459219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide for scleroderma lung disease.
    Martinez FJ; McCune WJ
    N Engl J Med; 2006 Jun; 354(25):2707-9. PubMed ID: 16790705
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.
    Apras S; Ertenli I; Ozbalkan Z; Kiraz S; Ozturk MA; Haznedaroglu IC; Cobankara V; Pay S; Calguneri M
    Arthritis Rheum; 2003 Aug; 48(8):2256-61. PubMed ID: 12905480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis.
    Calguneri M; Apras S; Ozbalkan Z; Ertenli I; Kiraz S; Ozturk MA; Celik I
    Clin Rheumatol; 2003 Oct; 22(4-5):289-94. PubMed ID: 14579158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.